Emmaus Life Sciences, Inc. Quarterly report [Sections 13 or 15(d)]

Selected Financial Statement - Assets

3 Months Ended

Mar. 31, 2026

NOTE 4 — SELECTED FINANCIAL STATEMENT — ASSETS

Inventories consisted of the following (in thousands):


	As of March 31, 2026			As of December 31, 2025
Raw materials and components	$	1,216		$	1,264
Work-in-process		582			26
Finished goods		5,185			5,343
Inventory reserve		(5,074	)		(5,078	)
Total inventories	$	1,909		$	1,555

Prepaid expenses and other current assets consisted of the following (in thousands):


	As of March 31, 2026		As of December 31, 2025
Prepaid insurance	$	345	$	529
Prepaid expenses		311		372
Other current assets		310		359
Total prepaid expenses and other current assets	$	966	$	1,260

Property and equipment consisted of the following (in thousands):


	As of March 31, 2026			As of December 31, 2025
Equipment	$	423		$	423
Leasehold improvements		16			16
Furniture and fixtures		30			30
Total property and equipment		469			469
Less: accumulated depreciation		(371	)		(356	)
Total property and equipment, net	$	98		$	113

For the three months ended March 31, 2026 and 2025, depreciation expense was approximately $15,000 and $5,000, respectively.